These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 11683573

  • 1. Treatment of epidermolysis bullosa acquisita with the humanized anti-Tac mAb daclizumab.
    Egan CA, Brown M, White JD, Yancey KB.
    Clin Immunol; 2001 Nov; 101(2):146-51. PubMed ID: 11683573
    [Abstract] [Full Text] [Related]

  • 2. Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis.
    Krueger JG, Walters IB, Miyazawa M, Gilleaudeau P, Hakimi J, Light S, Sherr A, Gottlieb AB.
    J Am Acad Dermatol; 2000 Sep; 43(3):448-58. PubMed ID: 10954656
    [Abstract] [Full Text] [Related]

  • 3. Epidermolysis bullosa acquisita: what's new?
    Ishii N, Hamada T, Dainichi T, Karashima T, Nakama T, Yasumoto S, Zillikens D, Hashimoto T.
    J Dermatol; 2010 Mar; 37(3):220-30. PubMed ID: 20507385
    [Abstract] [Full Text] [Related]

  • 4. Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantation.
    Baan CC, Balk AH, van Riemsdijk IC, Vantrimpont PJ, Maat AP, Niesters HG, Zondervan PE, van Gelder T, Weimar W.
    Transplantation; 2003 May 27; 75(10):1704-10. PubMed ID: 12777860
    [Abstract] [Full Text] [Related]

  • 5. Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita.
    Ishii N, Recke A, Mihai S, Hirose M, Hashimoto T, Zillikens D, Ludwig RJ.
    J Pathol; 2011 Jun 27; 224(2):234-44. PubMed ID: 21381035
    [Abstract] [Full Text] [Related]

  • 6. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
    Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens D, Sitaru C.
    J Pathol; 2004 Dec 27; 204(5):519-27. PubMed ID: 15538734
    [Abstract] [Full Text] [Related]

  • 7. Clinical response of severe mechanobullous epidermolysis bullosa acquisita to combined treatment with immunoadsorption and rituximab (anti-CD20 monoclonal antibodies).
    Niedermeier A, Eming R, Pfütze M, Neumann CR, Happel C, Reich K, Hertl M.
    Arch Dermatol; 2007 Feb 27; 143(2):192-8. PubMed ID: 17309999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Epidermolysis bullosa acquisita of childhood].
    Bordier-Lamy F, Eschard C, Coste M, Ploton D, Durlach A, Tabary T, Bernard P.
    Ann Dermatol Venereol; 2009 Feb 27; 136(6-7):513-7. PubMed ID: 19560612
    [Abstract] [Full Text] [Related]

  • 10. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature.
    Vodegel RM, de Jong MC, Pas HH, Jonkman MF.
    J Am Acad Dermatol; 2002 Dec 27; 47(6):919-25. PubMed ID: 12451379
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice.
    Hammers CM, Bieber K, Kalies K, Banczyk D, Ellebrecht CT, Ibrahim SM, Zillikens D, Ludwig RJ, Westermann J.
    J Immunol; 2011 Nov 15; 187(10):5043-50. PubMed ID: 21967893
    [Abstract] [Full Text] [Related]

  • 13. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy.
    Ishii N, Yoshida M, Ishida-Yamamoto A, Fritsch A, Elfert S, Bruckner-Tuderman L, Hashimoto T.
    Br J Dermatol; 2009 May 15; 160(5):1090-3. PubMed ID: 19067699
    [Abstract] [Full Text] [Related]

  • 14. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin.
    Campos M, Silvente C, Lecona M, Suárez R, Lázaro P.
    Clin Exp Dermatol; 2006 Jan 15; 31(1):71-3. PubMed ID: 16309488
    [Abstract] [Full Text] [Related]

  • 15. Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab.
    Wallet-Faber N, Franck N, Batteux F, Mateus C, Gilbert D, Carlotti A, Avril MF, Dupin N.
    Dermatology; 2007 Jan 15; 215(3):252-5. PubMed ID: 17823525
    [Abstract] [Full Text] [Related]

  • 16. Clearance rates of circulating and tissue-bound autoantibodies to type VII collagen in experimental epidermolysis bullosa acquisita.
    Kasperkiewicz M, Hirose M, Recke A, Schmidt E, Zillikens D, Ludwig RJ.
    Br J Dermatol; 2010 May 15; 162(5):1064-70. PubMed ID: 20222918
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S.
    Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Emerging treatment for epidermolysis bullosa acquisita.
    Engineer L, Ahmed AR.
    J Am Acad Dermatol; 2001 May 27; 44(5):818-28. PubMed ID: 11312431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.